2024-08-16 2025-08-31 false No description of principal activity Capium Accounts Production 1.1 15900380 2024-08-16 2025-08-31 15900380 bus:AbridgedAccounts 2024-08-16 2025-08-31 15900380 bus:Micro-entities 2024-08-16 2025-08-31 15900380 bus:AuditExempt-NoAccountantsReport 2024-08-16 2025-08-31 15900380 bus:SmallCompaniesRegimeForAccounts 2024-08-16 2025-08-31 15900380 bus:PrivateLimitedCompanyLtd 2024-08-16 2025-08-31 15900380 2024-08-16 2025-08-31 15900380 2025-08-31 15900380 bus:RegisteredOffice 2024-08-16 2025-08-31 15900380 core:WithinOneYear 2025-08-31 15900380 core:AfterOneYear 2025-08-31 15900380 1 2024-08-16 2025-08-31 15900380 bus:Director1 2024-08-16 2025-08-31 15900380 bus:Director1 2025-08-31 15900380 bus:Director2 2024-08-16 2025-08-31 15900380 bus:Director2 2025-08-31 15900380 2023-08-16 15900380 bus:LeadAgentIfApplicable 2024-08-16 2025-08-31 15900380 2024-08-15 15900380 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 15900380 core:CostValuation core:Non-currentFinancialInstruments 2024-08-15 15900380 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 15900380 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15900380 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15900380 core:Non-currentFinancialInstruments 2025-08-31 15900380 core:Non-currentFinancialInstruments 2024-08-15 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15900380
England and Wales
MM LIFE SCIENCES LIMITED
Abridged Accounts
Period of accounts Start date: 16 August 2024 End date: 31 August 2025

MM Life Sciences Limited Contents Page For the Period 16 August 2024 to 31 August 2025
Statement of financial position | 1

MM Life Sciences Limited Statement of Financial Position As at 31 August 2025
|  | 2025
--- | --- | ---
|  | £ | £
Current assets |  | 3,401 |
Creditors: amount falling due within one year |  | (1,050) |
Net current assets |  |  | 2,351
Total assets less current liabilities |  |  | 2,351
Net assets |  |  | 2,351
Capital and reserves |  |  | 2,351
NOTES TO THE ACCOUNTS General Information MM Life Sciences Limited is a private company, limited by shares, registered in England and Wales, registration number 15900380, registration address Suite 4989, Unit 3a,, Hatton Garden, Holborn, London, EC1N 8DX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Provisions Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2. | Average number of employees 0 Average number of employees during the period was 0.
For the period ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' Responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the board of directors on 15 May 2026 and were signed on its behalf by:
-------------------------------- Mohsan Shiraz MALIK Director
1